MARATTO

article · Laboratory Investigation

1072 Large-scale Validation Confirms Lack of Prognostic Impact of Aberrant p53 Status in POLEmut and MMRd Endometrial Carcinoma

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Angiogenesis and VEGF in Cancer

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.labinv.2025.105362

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.